These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 21095576)

  • 1. Inhibitor of fatty acid amide hydrolase normalizes cardiovascular function in hypertension without adverse metabolic effects.
    Godlewski G; Alapafuja SO; Bátkai S; Nikas SP; Cinar R; Offertáler L; Osei-Hyiaman D; Liu J; Mukhopadhyay B; Harvey-White J; Tam J; Pacak K; Blankman JL; Cravatt BF; Makriyannis A; Kunos G
    Chem Biol; 2010 Nov; 17(11):1256-66. PubMed ID: 21095576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of fatty acid amide hydrolase (FAAH) inhibitors on working memory in rats.
    Panlilio LV; Thorndike EB; Nikas SP; Alapafuja SO; Bandiera T; Cravatt BF; Makriyannis A; Piomelli D; Goldberg SR; Justinova Z
    Psychopharmacology (Berl); 2016 May; 233(10):1879-88. PubMed ID: 26558620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibiting fatty acid amide hydrolase normalizes endotoxin-induced enhanced gastrointestinal motility in mice.
    Bashashati M; Storr MA; Nikas SP; Wood JT; Godlewski G; Liu J; Ho W; Keenan CM; Zhang H; Alapafuja SO; Cravatt BF; Lutz B; Mackie K; Kunos G; Patel KD; Makriyannis A; Davison JS; Sharkey KA
    Br J Pharmacol; 2012 Mar; 165(5):1556-71. PubMed ID: 21883147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity.
    Gunduz-Cinar O; MacPherson KP; Cinar R; Gamble-George J; Sugden K; Williams B; Godlewski G; Ramikie TS; Gorka AX; Alapafuja SO; Nikas SP; Makriyannis A; Poulton R; Patel S; Hariri AR; Caspi A; Moffitt TE; Kunos G; Holmes A
    Mol Psychiatry; 2013 Jul; 18(7):813-23. PubMed ID: 22688188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors.
    Moreira FA; Kaiser N; Monory K; Lutz B
    Neuropharmacology; 2008 Jan; 54(1):141-50. PubMed ID: 17709120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of fatty-acid amide hydrolase accelerates acquisition and extinction rates in a spatial memory task.
    Varvel SA; Wise LE; Niyuhire F; Cravatt BF; Lichtman AH
    Neuropsychopharmacology; 2007 May; 32(5):1032-41. PubMed ID: 17047668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monounsaturated fatty acids generated via stearoyl CoA desaturase-1 are endogenous inhibitors of fatty acid amide hydrolase.
    Liu J; Cinar R; Xiong K; Godlewski G; Jourdan T; Lin Y; Ntambi JM; Kunos G
    Proc Natl Acad Sci U S A; 2013 Nov; 110(47):18832-7. PubMed ID: 24191036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of experimental spasticity by targeting the degradation of endocannabinoids using selective fatty acid amide hydrolase inhibitors.
    Pryce G; Cabranes A; Fernández-Ruiz J; Bisogno T; Di Marzo V; Long JZ; Cravatt BF; Giovannoni G; Baker D
    Mult Scler; 2013 Dec; 19(14):1896-904. PubMed ID: 23625705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor-mediated phenotypic hypoalgesia.
    Lichtman AH; Shelton CC; Advani T; Cravatt BF
    Pain; 2004 Jun; 109(3):319-327. PubMed ID: 15157693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting fatty acid amide hydrolase (FAAH) to treat pain and inflammation.
    Schlosburg JE; Kinsey SG; Lichtman AH
    AAPS J; 2009 Mar; 11(1):39-44. PubMed ID: 19184452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic profile, responsiveness to anandamide, and baroreflex sensitivity of mice lacking fatty acid amide hydrolase.
    Pacher P; Bátkai S; Osei-Hyiaman D; Offertáler L; Liu J; Harvey-White J; Brassai A; Járai Z; Cravatt BF; Kunos G
    Am J Physiol Heart Circ Physiol; 2005 Aug; 289(2):H533-41. PubMed ID: 15821037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertension and chronic inhibition of endocannabinoid degradation modify the endocannabinoid system and redox balance in rat heart and plasma.
    Biernacki M; Malinowska B; Timoszuk M; Toczek M; Jastrząb A; Remiszewski P; Skrzydlewska E
    Prostaglandins Other Lipid Mediat; 2018 Sep; 138():54-63. PubMed ID: 30201316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system.
    Cravatt BF; Lichtman AH
    Curr Opin Chem Biol; 2003 Aug; 7(4):469-75. PubMed ID: 12941421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic assessment of THC discriminative stimulus properties in fatty acid amide hydrolase knockout and wildtype mice.
    Walentiny DM; Vann RE; Wiley JL
    Neuropharmacology; 2015 Jun; 93():237-42. PubMed ID: 25698527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of anandamide transport in FAAH wild-type and knockout neurons: evidence for contributions by both FAAH and the CB1 receptor to anandamide uptake.
    Ortega-Gutiérrez S; Hawkins EG; Viso A; López-Rodríguez ML; Cravatt BF
    Biochemistry; 2004 Jun; 43(25):8184-90. PubMed ID: 15209515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of the endocannabinoid system in retinal damage after high intraocular pressure-induced ischemia in rats.
    Nucci C; Gasperi V; Tartaglione R; Cerulli A; Terrinoni A; Bari M; De Simone C; Agrò AF; Morrone LA; Corasaniti MT; Bagetta G; Maccarrone M
    Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):2997-3004. PubMed ID: 17591864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The endogenous cannabinoid anandamide produces delta-9-tetrahydrocannabinol-like discriminative and neurochemical effects that are enhanced by inhibition of fatty acid amide hydrolase but not by inhibition of anandamide transport.
    Solinas M; Tanda G; Justinova Z; Wertheim CE; Yasar S; Piomelli D; Vadivel SK; Makriyannis A; Goldberg SR
    J Pharmacol Exp Ther; 2007 Apr; 321(1):370-80. PubMed ID: 17210800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocannabinoid-mediated improvement on a test of aversive memory in a mouse model of fragile X syndrome.
    Qin M; Zeidler Z; Moulton K; Krych L; Xia Z; Smith CB
    Behav Brain Res; 2015 Sep; 291():164-171. PubMed ID: 25979787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arachidonoylserotonin and other novel inhibitors of fatty acid amide hydrolase.
    Bisogno T; Melck D; De Petrocellis L; Bobrov MYu ; Gretskaya NM; Bezuglov VV; Sitachitta N; Gerwick WH; Di Marzo V
    Biochem Biophys Res Commun; 1998 Jul; 248(3):515-22. PubMed ID: 9703957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The general anesthetic propofol increases brain N-arachidonylethanolamine (anandamide) content and inhibits fatty acid amide hydrolase.
    Patel S; Wohlfeil ER; Rademacher DJ; Carrier EJ; Perry LJ; Kundu A; Falck JR; Nithipatikom K; Campbell WB; Hillard CJ
    Br J Pharmacol; 2003 Jul; 139(5):1005-13. PubMed ID: 12839875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.